The Food and Drug Administration (FDA) has approved the emergency use of AstraZeneca Covid-19 vaccine and 50,000 doses of it will arrive in Thailand in February.
FDA secretary-general Paisarn Dunkum said on Thursday that the FDA approved the registration of the vaccine, produced in Italy by AstraZeneca Co, on Wednesday after the firm had submitted nearly 10,000 pages of its documents for vaccine registration for emergency use on Dec 22 last year.
The FDA had examined the documents by taking into consideration the efficacy and safety of the Covid-19 vaccine, said Dr Paisarn.
A total of 50,000 doses of the vaccine will arrive in Thailand in…
